Acadia Pharmaceuticals: What’s Next after the Negative FDA AdCom?
Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD), a biopharmaceutical company developing small molecule drugs for treating central nervous system disorders, faced a setback at the...
Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD), a biopharmaceutical company developing small molecule drugs for treating central nervous system disorders, faced a setback at the...
The Company Sunnova Energy International, Inc. (NYSE: NOVA) is a Houston, Texas-based provider of residential solar energy services in the United States and its...
Geron Corporation, Inc. (NASDAQ: GERN) is a late-stage clinical biotechnology company developing a first-in-class telomerase inhibitor, imetelstat, intended to treat hematologic malignancies. The...
Drive Shack, Inc. (NYSE: DS), formerly known as Newcastle Investment Corp, is a golf-related leisure and entertainment company, which owns, leases, and manages 55...
Twist Biosciences, Inc. (NASDAQ: TWST) manufactures and sells synthetic DNA-based products by leveraging the Company’s DNA synthesis platform that helps write DNA on...
Harmony Biosciences, Inc. (NASDAQ: HRMY) is a commercial-stage biopharmaceutical Company developing novel therapeutics for rare and orphan diseases, focusing on central nervous system...
Kratos Security and Defense Solutions, Inc. (NASDAQ: KTOS) is a mid-sized defense technology company developing cutting-edge transformative systems and platforms for national security...
A Leading Carbon Negative Materials Company Origin Materials, Inc. (NASDAQ: ORGN) is a premier material-technology Company focused on facilitating the world’s transition to sustainable...
On May 19, 2022, The Siga Technologies, Inc. (NASDAQ: SIGA) announced the approval of its intravenous (IV) formulation of TPOXX® (tecovirimat) by the...